tm logo
Live/Registered
REGISTERED

on 09 Apr 2024

Last Applicant/ Owned by

50 Northern Avenue

Boston

MA

02210

Serial Number

97609470 filed on 27th Sep 2022

Registration Number

7356920 registered on 09th Apr 2024

in the Principal Register

Correspondent Address

Sarah Anne Keefe

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

Logo Mark Trademark Information

Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia


First Use Date in General

16th Nov 2023

First Use Date in Commerce

08th Dec 2023

Mark Details


Serial Number

No 97609470

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.06 -

Semi-circles

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.02 -

Wavy line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

26.17.06 -

Diagonal line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
09th Apr 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th Apr 2024REGISTERED-PRINCIPAL REGISTER
06th Mar 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05th Mar 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05th Mar 2024STATEMENT OF USE PROCESSING COMPLETE
04th Mar 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
12th Feb 2024TEAS STATEMENT OF USE RECEIVED
12th Feb 2024USE AMENDMENT FILED
29th Sep 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Sep 2023SOU EXTENSION 1 GRANTED